Nykredit A S Buys Shares of 41,672 HCA Healthcare, Inc. $HCA

Key Points

• Nykredit A/S initiated a position in HCA Healthcare, buying 41,672 shares valued at approximately $16.25 million. Institutional investors collectively own 62.73% of the company.
• HCA Healthcare exceeded quarterly expectations, reporting $7.59 in earnings per share and $20.23 billion in revenue, with revenue rising 8.7% year over year.
• The company announced a quarterly dividend of $0.78 per share, while analysts maintain a “Moderate Buy” consensus rating and a $462.64 average price target.

Nykredit A S bought a new position in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) during the 2nd quarter, according to its most recent disclosure with the SEC. The institutional investor bought 41,672 shares of the company's stock, valued at approximately $16,247,000.

Several other institutional investors have also recently added to or reduced their stakes in HCA. Robbins Farley boosted its holdings in shares of HCA Healthcare by 9.0% in the 2nd quarter. Robbins Farley now owns 4,368 shares of the company's stock valued at $1,703,000 after buying an additional 361 shares in the last quarter. MBA Advisors LLC acquired a new stake in shares of HCA Healthcare during the second quarter worth $311,000. Symphony Financial Ltd. Co. purchased a new position in HCA Healthcare during the second quarter worth about $291,000. Proficio Capital Partners LLC acquired a new position in HCA Healthcare during the 2nd quarter worth approximately $343,000. Finally, CTC Alternative Strategies Ltd. purchased a new position in HCA Healthcare in the 2nd quarter valued at approximately $265,000. Hedge funds and other institutional investors own 62.73% of the company's stock.

HCA Healthcare Price Performance

NYSE:HCA opened at $404.95 on Friday. The stock's 50-day moving average is $403.35 and its two-hundred day moving average is $437.55. HCA Healthcare, Inc. has a fifty-two week low of $353.99 and a fifty-two week high of $556.52. The stock has a market cap of $87.67 billion, a PE ratio of 13.56, a price-to-earnings-growth ratio of 1.35 and a beta of 1.10.

HCA Healthcare (NYSE:HCA - Get Free Report) last announced its quarterly earnings results on Friday, July 24th. The company reported $7.59 EPS for the quarter, topping the consensus estimate of $7.56 by $0.03. HCA Healthcare had a net margin of 8.77% and a negative return on equity of 244.79%. The company had revenue of $20.23 billion for the quarter, compared to analyst estimates of $19.76 billion. During the same quarter in the prior year, the business posted $6.84 EPS. HCA Healthcare's quarterly revenue was up 8.7% on a year-over-year basis. On average, equities research analysts anticipate that HCA Healthcare, Inc. will post 29.42 earnings per share for the current year.

HCA Healthcare Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, September 30th. Investors of record on Wednesday, September 16th will be paid a $0.78 dividend. The ex-dividend date of this dividend is Wednesday, September 16th. This represents a $3.12 dividend on an annualized basis and a yield of 0.8%. HCA Healthcare's payout ratio is presently 10.45%.

Analyst Ratings Changes

HCA has been the topic of several analyst reports. Barclays decreased their price objective on HCA Healthcare from $402.00 to $387.00 and set an "equal weight" rating on the stock in a report on Monday, July 27th. Mizuho lowered their price target on shares of HCA Healthcare from $525.00 to $475.00 and set an "outperform" rating for the company in a report on Tuesday, July 28th. Truist Financial reduced their price objective on shares of HCA Healthcare from $535.00 to $495.00 and set a "buy" rating on the stock in a research note on Monday, July 27th. Jefferies Financial Group set a $450.00 price objective on HCA Healthcare in a research note on Tuesday, July 14th. Finally, TD Cowen dropped their price target on shares of HCA Healthcare from $500.00 to $431.00 and set a "buy" rating on the stock in a research note on Monday, June 22nd. Fourteen research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has assigned a Sell rating to the company's stock. Based on data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and a consensus price target of $462.64.

About HCA Healthcare

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company's core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA's services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source